Cypress Bioscience, Inc. (NASDAQ:CYPB.DL)

CAPS Rating: No stars

The Company provides products for the treatment of patients with Functional Somatic Syndromes and other central nervous system disorders.

CYPB.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top CYPB.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

stockblog (< 20)
Submitted October 03, 2008

Since I last wrote about Cypress Bioscience (CYPB) two months ago, the stock has moved lower with the Company now trading even closer to its net cash position of $4 per share with a closing price on Friday of $6.43 per share. The level of short… More

Renton405 (31.94)
Submitted May 05, 2009

Savella is just another SNRI antidepressant drug. It has the exact same fuction as Effexor and Cymbalta, both of which are also SNRIs. There are already enough SNRIs on the market today. Pushing another drug that has the exact same function as… More

CYPB.DL VS S&P 500 (SPY)

CYPB.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CYPB.DL.

No one has written a Pitch for CYPB.DL stock yet. Tell us why you think CYPB.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in CYPB.DL.

No players have picked CYPB.DL yet. Tell us why you think CYPB.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRothCapital 72.52 12/11/2009 Outperform NS $5.51 +17.97% +15.53% +2.43 1/14/2011 @ $6.50 0 Comment
TrackOppenheimer 69.59 10/31/2009 Outperform NS $6.50 0% +20.76% -20.76 1/14/2011 @ $6.50 0 Comment
TrackZacks < 20 12/19/2008 Outperform 3M $5.93 +33.73% -2.70% +36.43 4/11/2009 @ $7.93 1 Comment
TrackPiperJaff 85.13 12/16/2008 Outperform NS $6.00 +8.33% +45.38% -37.05 1/14/2011 @ $6.50 0 Comment
TrackOppenheimer 69.59 12/1/2008 Outperform NS $5.23 +43.59% -6.82% +50.42 3/25/2009 @ $7.51 0 Comment
TrackRBCCapMkts 87.09 10/7/2008 Outperform NS $6.35 +2.36% +20.19% -17.82 1/14/2011 @ $6.50 0 Comment
TrackFBRCapitalM 90.38 10/2/2007 Outperform NS $14.36 -43.73% -18.96% -24.78 7/10/2008 @ $8.08 0 Comment
TrackCitigroup 93.24 9/18/2007 Outperform NS $14.37 -54.77% -13.75% -41.02 1/14/2011 @ $6.50 0 Comment
TrackJefferies 83.36 5/23/2007 Outperform NS $17.39 -62.62% -16.07% -46.55 1/14/2011 @ $6.50 0 Comment
TrackPZK < 20 3/5/2007 Outperform NS $7.61 -14.59% -7.39% -7.19 1/14/2011 @ $6.50 0 Comment

Featured Broker Partners